# Weixin Hu

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/weixin-hu/

## Facts

| Field | Value |
| --- | --- |
| Citations | 2,692 |
| Field | Systemic Lupus Erythematosus Research |
| h-index | 26 |
| i10-index | 46 |
| Last Known Institution | Shenzhen University |
| OpenAlex ID | https://openalex.org/A5101554992 |
| ORCID iD | 0000-0002-6263-6149 |
| Works | 97 |

## Researcher papers

- [Multitarget Therapy for Induction Treatment of Lupus Nephritis](https://scholariq.org/papers/multitarget-therapy-for-induction-treatment-of-lupus-nephritis/)
- [Intrauterine Growth Restriction Affects the Proteomes of the Small Intestine, Liver, and Skeletal Muscle in Newborn Pigs](https://scholariq.org/papers/intrauterine-growth-restriction-affects-the-proteomes-of-the-small-intestine/)
- [Successful Treatment of Class V+IV Lupus Nephritis with Multitarget Therapy](https://scholariq.org/papers/successful-treatment-of-class-v-iv-lupus-nephritis-with-multitarget-therapy/)
- [Mycophenolate mofetil versus cyclophosphamide for inducing remission of ANCA vasculitis with moderate renal involvement](https://scholariq.org/papers/mycophenolate-mofetil-versus-cyclophosphamide-for-inducing-remission-of-anca/)
- [Mycophenolate mofetil vs cyclophosphamide therapy for patients with diffuse proliferative lupus nephritis.](https://scholariq.org/papers/mycophenolate-mofetil-vs-cyclophosphamide-therapy-for-patients-with-diffuse/)
- [Clinical–Morphological Features and Outcomes of Lupus Podocytopathy](https://scholariq.org/papers/clinical-morphological-features-and-outcomes-of-lupus-podocytopathy/)
- [Risk factors for infectious complications of ANCA-associated vasculitis: a cohort study](https://scholariq.org/papers/risk-factors-for-infectious-complications-of-anca-associated-vasculitis-a-cohort/)
- [Etiology and Outcome of Crescentic Glomerulonephritis From a Single Center in China: A 10-Year Review](https://scholariq.org/papers/etiology-and-outcome-of-crescentic-glomerulonephritis-from-a-single-center-in/)
- [Long-term outcome of Chinese patients with membranous lupus nephropathy](https://scholariq.org/papers/long-term-outcome-of-chinese-patients-with-membranous-lupus-nephropathy/)
- [The short-term efficacy of bortezomib combined with glucocorticoids for the treatment of refractory lupus nephritis](https://scholariq.org/papers/the-short-term-efficacy-of-bortezomib-combined-with-glucocorticoids-for-the/)
- [Differences in clinico-pathological characteristics and outcomes between proteinase 3-ANCA positivity and myeloperoxidase-ANCA positivity in lupus nephritis](https://scholariq.org/papers/differences-in-clinico-pathological-characteristics-and-outcomes-between/)
- [Long-term renal outcomes and related risk factors of familial systemic lupus erythematosus patients with lupus nephritis](https://scholariq.org/papers/long-term-renal-outcomes-and-related-risk-factors-of-familial-systemic-lupus/)

## Researcher topics

- [Systemic Lupus Erythematosus Research](https://scholariq.org/topics/systemic-lupus-erythematosus-research/)
- [Renal Diseases and Glomerulopathies](https://scholariq.org/topics/renal-diseases-and-glomerulopathies/)
- [Vasculitis and related conditions](https://scholariq.org/topics/vasculitis-and-related-conditions/)
- [Systemic Sclerosis and Related Diseases](https://scholariq.org/topics/systemic-sclerosis-and-related-diseases/)
- [Liver Diseases and Immunity](https://scholariq.org/topics/liver-diseases-and-immunity/)

## Researcher university

- [Shenzhen University](https://scholariq.org/institutions/shenzhen-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.